IL134378A - A complex that neutralizes the charge of aprosartan arginine, its preparation and pharmaceutical preparations containing it - Google Patents
A complex that neutralizes the charge of aprosartan arginine, its preparation and pharmaceutical preparations containing itInfo
- Publication number
- IL134378A IL134378A IL13437898A IL13437898A IL134378A IL 134378 A IL134378 A IL 134378A IL 13437898 A IL13437898 A IL 13437898A IL 13437898 A IL13437898 A IL 13437898A IL 134378 A IL134378 A IL 134378A
- Authority
- IL
- Israel
- Prior art keywords
- composition according
- compound
- medicament
- pharmaceutical composition
- diuretic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5499097P | 1997-08-06 | 1997-08-06 | |
PCT/US1998/016245 WO1999007365A1 (en) | 1997-08-06 | 1998-08-04 | Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
IL134378A0 IL134378A0 (en) | 2001-04-30 |
IL134378A true IL134378A (en) | 2004-02-19 |
Family
ID=21994861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13437898A IL134378A (en) | 1997-08-06 | 1998-08-04 | A complex that neutralizes the charge of aprosartan arginine, its preparation and pharmaceutical preparations containing it |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1027047B1 (zh) |
JP (1) | JP4463975B2 (zh) |
KR (1) | KR100508044B1 (zh) |
CN (1) | CN1276724A (zh) |
AR (1) | AR015930A1 (zh) |
AT (1) | ATE341325T1 (zh) |
AU (1) | AU739295B2 (zh) |
BR (1) | BR9811926A (zh) |
CA (1) | CA2299470C (zh) |
CO (1) | CO4960666A1 (zh) |
CY (1) | CY1105851T1 (zh) |
CZ (1) | CZ296274B6 (zh) |
DE (1) | DE69836095T2 (zh) |
DK (1) | DK1027047T3 (zh) |
ES (1) | ES2273433T3 (zh) |
HK (1) | HK1031688A1 (zh) |
HU (1) | HUP0201624A3 (zh) |
IL (1) | IL134378A (zh) |
NO (1) | NO317771B1 (zh) |
NZ (1) | NZ502644A (zh) |
PL (1) | PL198875B1 (zh) |
PT (1) | PT1027047E (zh) |
SA (1) | SA98190592B1 (zh) |
TR (1) | TR200000350T2 (zh) |
TW (1) | TW570921B (zh) |
WO (1) | WO1999007365A1 (zh) |
ZA (1) | ZA987018B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA991922B (en) * | 1998-03-11 | 1999-09-13 | Smithkline Beecham Corp | Novel compositions of eprosartan. |
EP1197223B1 (en) * | 1999-04-28 | 2005-02-16 | Takeda Pharmaceutical Company Limited | Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy |
BRPI0406987A (pt) | 2003-01-31 | 2006-01-10 | Sankyo Co | Medicamento para a prevenção e/ou tratamento de arteriosclerose, medicamentos para a inibição de proliferação de células do músculo liso vascular, de formação de neoìntima dos vasos sanguìneos e de remodelação vascular, medicamento para a prevenção de restenose que segue intervenção coronária percutânea, e, medicamentos para a profilaxia e/ou tratamento de hipertensão ou doenças causadas por hipertensão ou doenças causadas por hipertensão, de doenças cardìacas, de angina do peito, de infarto miocárdico, de arritmia, de morte súbita, de insuficiência cardìaca, de hipertrofia cardìaca, de doenças renais, de nefropatia diabética, de glomerulonefrite, de nefrosclerose, de doenças cerebrovasculares, de infarto cerebral, e de hemorragia cerebral |
NO323391B1 (no) | 2005-09-28 | 2007-04-23 | Hts Hans Torgersen & Sonn As | Barnepose |
EP2167047A2 (en) * | 2007-06-06 | 2010-03-31 | Dexcel Ltd. | Process for forming solid oral dosage forms of angiotensin ii receptor antagonists |
JP5476782B2 (ja) * | 2009-04-21 | 2014-04-23 | 大正製薬株式会社 | アルギニン含有錠剤の製造方法 |
JP5446716B2 (ja) * | 2009-10-21 | 2014-03-19 | 大正製薬株式会社 | アルギニン及びカルニチン含有錠剤の製造方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
NZ239161A (en) * | 1990-07-31 | 1994-01-26 | Smithkline Beecham Corp | Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments, |
DE69131021T2 (de) * | 1990-12-14 | 1999-08-12 | Smithkline Beecham Corp | Angiotensin-ii-rezeptor blockierende zusammensetzungen |
JP3214856B2 (ja) * | 1990-12-14 | 2001-10-02 | スミスクライン・ビーチャム・コーポレイション | イミダゾリル−アルケン酸 |
US5187159A (en) * | 1991-10-07 | 1993-02-16 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole |
DE4208052A1 (de) * | 1992-03-13 | 1993-09-16 | Bayer Ag | Imidazolyl substituierte phenylessigsaeureamide |
FR2688781B1 (fr) * | 1992-03-23 | 1994-07-01 | Sanofi Elf | Imidazolines n-substituees par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant. |
DE4210787A1 (de) * | 1992-04-01 | 1993-10-07 | Bayer Ag | Cycloalkyl- und Heterocyclyl substituierte Imidazolylpropensäurederivate |
JPH0841053A (ja) * | 1994-07-28 | 1996-02-13 | Nkk Corp | ヘテロアリールアルキル基を有するピリミジン誘導体及 び該誘導体を有効成分として含有するアンジオテンシン ii拮抗剤 |
US5645839A (en) * | 1995-06-07 | 1997-07-08 | Trustees Of Boston University | Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis |
WO1997021707A1 (en) * | 1995-12-14 | 1997-06-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
-
1998
- 1998-08-04 CZ CZ20000406A patent/CZ296274B6/cs not_active IP Right Cessation
- 1998-08-04 HU HU0201624A patent/HUP0201624A3/hu unknown
- 1998-08-04 AT AT98939213T patent/ATE341325T1/de active
- 1998-08-04 DE DE69836095T patent/DE69836095T2/de not_active Expired - Lifetime
- 1998-08-04 ES ES98939213T patent/ES2273433T3/es not_active Expired - Lifetime
- 1998-08-04 EP EP98939213A patent/EP1027047B1/en not_active Expired - Lifetime
- 1998-08-04 DK DK98939213T patent/DK1027047T3/da active
- 1998-08-04 JP JP2000506956A patent/JP4463975B2/ja not_active Expired - Fee Related
- 1998-08-04 CN CN98809802A patent/CN1276724A/zh active Pending
- 1998-08-04 NZ NZ502644A patent/NZ502644A/en unknown
- 1998-08-04 PL PL341562A patent/PL198875B1/pl not_active IP Right Cessation
- 1998-08-04 WO PCT/US1998/016245 patent/WO1999007365A1/en active IP Right Grant
- 1998-08-04 KR KR10-2000-7001173A patent/KR100508044B1/ko not_active IP Right Cessation
- 1998-08-04 BR BR9811926-5A patent/BR9811926A/pt not_active Application Discontinuation
- 1998-08-04 TR TR2000/00350T patent/TR200000350T2/xx unknown
- 1998-08-04 AU AU87688/98A patent/AU739295B2/en not_active Ceased
- 1998-08-04 IL IL13437898A patent/IL134378A/en not_active IP Right Cessation
- 1998-08-04 PT PT98939213T patent/PT1027047E/pt unknown
- 1998-08-04 CA CA2299470A patent/CA2299470C/en not_active Expired - Fee Related
- 1998-08-05 ZA ZA987018A patent/ZA987018B/xx unknown
- 1998-08-05 AR ARP980103871A patent/AR015930A1/es active IP Right Grant
- 1998-08-10 CO CO98045455A patent/CO4960666A1/es unknown
- 1998-08-26 TW TW087112928A patent/TW570921B/zh not_active IP Right Cessation
- 1998-09-27 SA SA98190592A patent/SA98190592B1/ar unknown
-
2000
- 2000-02-04 NO NO20000577A patent/NO317771B1/no not_active IP Right Cessation
-
2001
- 2001-01-31 HK HK01100711A patent/HK1031688A1/xx not_active IP Right Cessation
-
2006
- 2006-12-13 CY CY20061101797T patent/CY1105851T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6630498B2 (en) | Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation | |
AU763309B2 (en) | Bioenhanced formulations comprising eprosartan in oral solid dosage form | |
US6558699B2 (en) | High drug load immediate and modified release oral dosage formulations and processes for their manufacture | |
AU750611B2 (en) | High drug load immediate and modified release oral dosage formulations and processes for their manufacture | |
CA2299470C (en) | Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation | |
MXPA00001385A (en) | Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation | |
MXPA00004791A (en) | High drug load immediate and modified release oral dosage formulations and processes for their manufacture | |
CZ20001802A3 (cs) | Orální dávkové prostředky s okamžitým nebo modifikovaným uvolňováním vysoké náplně léčiva a způsoby jejich přípravy | |
CZ2001227A3 (cs) | Biologicky zlepšené prostředky obsahující eprosartan v orální pevné dávkové formě |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |